Motus is a neurotechnology company developing brain-computer interfaces for motor rehabilitation, with a focus on stroke recovery and motor function restoration. The company's platform combines non-invasive EEG with robotic rehabilitation devices to create closed-loop motor rehabilitation systems[1]. Motus has established itself as a leading provider of BCI-based rehabilitation technology, with FDA-cleared products used in clinical settings worldwide.
Motus was founded with the mission of developing innovative rehabilitation technologies that leverage brain-computer interfaces to help patients recover motor function after neurological injuries. The company's early work focused on developing the core technology platform combining EEG-based neural recording with rehabilitation robotics.
The Motus platform is a comprehensive rehabilitation solution:
Motus BCI has demonstrated significant benefits for stroke rehabilitation:
For patients with MS-related motor impairment:
Applications for Parkinson's disease patients:
Motor recovery applications for TBI patients:
For ALS patients:
Multiple clinical trials have demonstrated Motus BCI effectiveness:
Clinical rehabilitation system for inpatient and outpatient settings:
Home-based version for continuous rehabilitation:
Research platform for neuroscience studies:
| Feature | Motus | MindMaze | BCI Rehabilitation | OpenBCI |
|---|---|---|---|---|
| Channels | 64+ | 8-16 | 8-32 | 8-32 |
| EEG Type | High-density | Dry | Wet | Wet/Dry |
| Robotics | Integrated | Optional | Optional | Research |
| FDA Status | FDA Cleared | FDA Cleared | Investigational | Research |
| Clinical Use | Wide | Growing | Limited | Research |
| Home Version | Available | Limited | Limited | Research |
Motus. Technology Platform. ↩︎